AKT1 and meningioma: The AKT1 variant AKT1E17K found in meningiomas activates the mTOR signaling pathway, which promotes cell growth, survival, and proliferation while inhibiting apoptosis (Davies et al. 2015; Rascio et al. 2021; John et al. 2022).